Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer

SIMPLE SUMMARY: Identifying which men at the time of prostate cancer diagnosis have, or will progress to, an aggressive fatal disease will allow clinicians to assist men in making better informed treatment decisions. This will not only be important for those men whose disease is likely to remain ind...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Nguyen-Dumont, Tú, Dowty, James G., MacInnis, Robert J., Steen, Jason A., Riaz, Moeen, Dugué, Pierre-Antoine, Renault, Anne-Laure, Hammet, Fleur, Mahmoodi, Maryam, Theys, Derrick, Tsimiklis, Helen, Severi, Gianluca, Bolton, Damien, Lacaze, Paul, Sebra, Robert, Schadt, Eric, McNeil, John, Giles, Graham G., Milne, Roger L., Southey, Melissa C.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036662/
https://ncbi.nlm.nih.gov/pubmed/33804961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071495
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados